Endo Pharmaceuticals Gives Update on
Regulatory Status of Testosterone Undecanoate for Men with Hypogonadism Press Release Source: Endo Pharmaceuticals On Wednesday September 2, 2009, 4:05 pm EDT CHADDS FORD, Pa., Sept. 2 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP - News) announced today that it has been informed by the U.S. Food and Drug Administration (FDA) that the agency has...